|
T.TH
|
Trilium therapeutics has jumped 5000% this year on the heels of a couple...
|
|
T.TH
|
The Sortilin/Progranulin axis is clearly becoming a hot topic of research in...
|
|
T.TH
|
I just noticed this article from the September issue of American Journal of...
|
|
T.TH
|
By the way, I'm always quoting USD prices, as is the norm for the company...
|
|
T.TH
|
Right, hopefully it won't have that magnitude! 12% is just my rule of...
|
|
T.TH
|
I think the same as you, a probable (healthy) raise of 15-20M, capped by a...
|
|
T.TH
|
Anyway, whatever is the normal explanation for this phenomenon, it's been...
|
|
T.TH
|
Yes, you are right, up to know there's been little effect on the long...
|
|
T.TH
|
That's an interesting idea.. maybe arbitrageurs are part of the picture...
|
|
T.TH
|
That was from me, and the data is from shortvolume.com. As a word of caution,...
|
|
T.TH
|
It mostly means the trial will comprise surrogate endpoints, instead of full...
|
|
T.TH
|
(hopefully it only does that on my old laptop, but pages 23 and beyond take a...
|
|
T.TH
|
https://www.theratech.com/wp-content/uploads/2020/09/FINAL-IR-Deck-9-11-20...
|
|
T.TH
|
"I don't remember any interim results in the lipo trials of...
|
|
T.TH
|
I think you are confused by the currencies. SPCEO's sales number look...
|
|
T.TH
|
Thank you for those clarifications, that's reassuring! SPCEO1 wrote...
|
|
T.TH
|
.. or maybe they can't do anything about it because composition of matter...
|
|
T.TH
|
it seems it's not so much "off-label" use as outright illicit...
|
|
T.TH
|
True.. I can see the trial of tesamorelin for improvement of cognition in...
|
|
T.TH
|
Looks like some crazy people are willing to buy tesamorelin from dubious...
|